the 1-, 3-, and 5-year patient and graft survival rates were 84.6%, 84.6%, and 70.5% and 84.6%, 84.6%, and 84.6%, respectively, with a median follow-up of 35 months(range ¼ 2-73 months).
Baccarani U, Adani GL, Tavio M, Viale P (2011). Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection--21 plus 13. HEPATOLOGY, 53, 2138-2138 [10.1002/hep.24287].
Liver transplantation for hepatocellular carcinoma: the impact of human immunodeficiency virus infection--21 plus 13.
VIALE, PIERLUIGI
2011
Abstract
the 1-, 3-, and 5-year patient and graft survival rates were 84.6%, 84.6%, and 70.5% and 84.6%, 84.6%, and 84.6%, respectively, with a median follow-up of 35 months(range ¼ 2-73 months).File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
